USFDA commences inspection at Indoco Remedies’ Goa Plant I

18 Jan 2019 Evaluate

US Food and Drug Administration (USFDA) has commenced inspection at Indoco Remedies’ Goa Plant I (Solid oral facility) since January 17, 2019. Inspection of Goa Plant II (Sterile facility) was completed from November14- 21, 2018.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

196.00 -0.20 (-0.10%)
11-Mar-2026 13:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.60
Dr. Reddys Lab 1326.25
Cipla 1335.00
Zydus Lifesciences 927.95
Lupin 2365.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×